Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Diffuse Large B Cell Lymphoma
Related studies linked through entity extraction aliases.
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Early Palliative Care for Patients With Haematological Malignancies
- Status
- UNKNOWN
- Phase
- PHASE3
Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Lenalidomide Based Immunotherapy in the Treatment of DLBCL
- Status
- UNKNOWN
- Phase
- N/A
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Trial of Radiotherapy and Durvalumab in DLBCL and FL
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE4
Trial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE4
Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
- Status
- TERMINATED
- Phase
- N/A
Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1